Home / Health / Future of Medicine / New Immunotherapy Treatment Successful in Treating Breast Cancer
Operating Room Doctors

New Immunotherapy Treatment Successful in Treating Breast Cancer

A woman with advanced metastatic breast cancer was treated with boosted versions of her own body’s disease-fighting cells, leading to a complete disappearance of her tumors and regression for nearly two years.

The technique involving tumor infiltrating lymphocytes, or TILs, had been used to treat other cancers, but only now is being tried against breast cancer. Now, the technique, “represents a new immunotherapy approach for the treatment of these patients,” researchers from the National Cancer Institute wrote in a paper on their research in Nature Medicine. 

The lymphocytes are typically present in certain kinds of tumors but aren’t numerous enough to fight the cancer. Different lymphocytes attack different mutant proteins – so doctors have to find ones that are just to right to attack the tumor, and remove them from the patient’s body. They then can grow the TILs outside the patient, and put them back in much larger numbers to fight the particular type of cancerous tumor.

In the meantime, the patient was also treated immunotherapy drug Keytruda.

The NCI’s Steven Rosenberg told Forbes that the TILs are simply multiplied – not engineered – outside the patient’s body before being returned in larger numbers to fight the cancer.

“They are natural T-cells, not genetically engineered,” Rosenberg told the magazine. “This is the most highly personalized treatment you can imagine…. These treatments have the potential to treat patients with any cancer.”

Forbes noted that several companies are running trials for TIL therapies. Clinical trials are using the technique to target melanoma, cervical cancer, lung cancer, pancreatic cancer and others.

“This is a change in our thinking about what might be needed to treat these cancers,” Rosenberg told Forbes. “A new paradigm for cancer therapy.”

 

About LedeTree

LedeTree
LedeTree combines original content and curated aggregation in order to give you intelligent information. From LedeTree original reporting to newspapers to social media to law makers to direct communication through LedeTree, we have a place for you to speak your mind, be heard, and let our editors get to the truth behind the stories.

Check Also

Genetic Editing Stock Photo

Study: Damage to Genes From CRISPR Editing More Than Thought

Editing genes with CRISPR could cause significantly greater genetic havoc than experts thought, a new …

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.